ES2177989T3 - Diagnosis de la pre-eclampsia. - Google Patents

Diagnosis de la pre-eclampsia.

Info

Publication number
ES2177989T3
ES2177989T3 ES97931904T ES97931904T ES2177989T3 ES 2177989 T3 ES2177989 T3 ES 2177989T3 ES 97931904 T ES97931904 T ES 97931904T ES 97931904 T ES97931904 T ES 97931904T ES 2177989 T3 ES2177989 T3 ES 2177989T3
Authority
ES
Spain
Prior art keywords
diagnosis
eclampsy
blood
clamplsia
inhibine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97931904T
Other languages
English (en)
Inventor
Nigel Patrick Groome
Philip Gerald Knight
William Leigh Ledger
Christopher Willard Geo Redman
Shanthi Muttukrishna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Reading
Oxford University Innovation Ltd
Oxford Brookes University
Original Assignee
University of Reading
Oxford University Innovation Ltd
Oxford Brookes University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Reading, Oxford University Innovation Ltd, Oxford Brookes University filed Critical University of Reading
Application granted granted Critical
Publication of ES2177989T3 publication Critical patent/ES2177989T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A UN PROCEDIMIENTO DE DIAGNOSTICO DE PREECLAMPLSIA QUE CONSISTE EN MEDIR LA HORMONA INHIBINA A EN UNA MUESTRA TAL COMO LA SANGRE MATERNA. ESTE PROCEDIMIENTO NO INVASIVO PERMITE ESTABLECER UN DIAGNOSTICO PRECOZ Y PREDECIR LA APARICION DE SINTOMAS SECUNDARIOS.
ES97931904T 1996-07-11 1997-07-11 Diagnosis de la pre-eclampsia. Expired - Lifetime ES2177989T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9614615.4A GB9614615D0 (en) 1996-07-11 1996-07-11 Diagnosis of pre-eclampsia

Publications (1)

Publication Number Publication Date
ES2177989T3 true ES2177989T3 (es) 2002-12-16

Family

ID=10796766

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97931904T Expired - Lifetime ES2177989T3 (es) 1996-07-11 1997-07-11 Diagnosis de la pre-eclampsia.

Country Status (5)

Country Link
EP (1) EP0927355B1 (es)
DE (1) DE69712899T2 (es)
ES (1) ES2177989T3 (es)
GB (1) GB9614615D0 (es)
WO (1) WO1998002751A1 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9812432D0 (en) * 1998-06-09 1998-08-05 Queen Mary & Westfield College Predictive test
WO2002032953A2 (en) 2000-10-20 2002-04-25 Como Biotech Aps Pregnancy-associated plasma protein-a2 (papp-a2)
AU2002953327A0 (en) * 2002-12-12 2003-01-09 Monash University Methods of diagnosing prognosing and treating activin associated diseases and conditions
CN101616927A (zh) * 2005-09-15 2009-12-30 迪爱麦有限公司 诊断先兆子痫的方法
WO2014036440A2 (en) * 2012-08-30 2014-03-06 Ansh Labs Llc Papp-a2 as a marker for monitoring, predicting and diagnosing preeclampsia

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU599373B2 (en) * 1986-03-13 1990-07-19 Biotechnology Australia Proprietary Limited Method of assay of inhibin
US5079171A (en) * 1988-09-15 1992-01-07 Adeza Biomedical Corporation Determining pregnancy induced hypertension and eclampsia by immunoassay of cellular fibronectin
GB9416415D0 (en) * 1994-08-13 1994-10-05 Kodak Ltd Antenatel screening for pregnacy abnormalities
US5545616A (en) * 1994-09-22 1996-08-13 Genentech, Inc. Method for predicting and/or preventing preterm labor

Also Published As

Publication number Publication date
DE69712899T2 (de) 2003-01-16
WO1998002751A1 (en) 1998-01-22
DE69712899D1 (de) 2002-07-04
EP0927355A1 (en) 1999-07-07
EP0927355B1 (en) 2002-05-29
GB9614615D0 (en) 1996-09-04

Similar Documents

Publication Publication Date Title
ES2160716T3 (es) Procedimiento para estabilizar la respuesta de un biosensor.
TR199800815A2 (en) S�lfonilaminokarbonasitler.
BR0206604A (pt) Dispositivo de lanceta que tem ação capilar
SE7906148L (sv) Forfarande for framstellning av en biologisk komposition for anvendning sasom referenskontroll vid diagnostiska tester
NO20006681D0 (no) Fremgangsmåte ved tidlig diagnose av karsinomer
DE69907155D1 (de) Krebsbehandlung
DE69005840D1 (de) Analytisches Element zur Untersuchung des gesamten Blutes.
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
ES2177989T3 (es) Diagnosis de la pre-eclampsia.
ATE104840T1 (de) Diagnostisches hauttestgeraet.
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
DE69841322D1 (de) Hepatitis c rezeptorprotein cd81
DE60012140D1 (de) Verwendung von urintrypsininhibitor zur diagnose von aids
ES2075169T3 (es) Agentes de union especifica.
DE60135918D1 (de) Gerät für prostatekrebsdiagnose
BRPI0415212A (pt) método de diagnose da doença de alzheimer ou estágio inicial ou predisposição para a mesma e respectivo kit de diagnose
AR220329A1 (es) Composicion de ensayo para determinar la presencia de sangre o peroxidasa en una muestra de ensayo,dispositivo que la comprende y procedimiento para preparar el dispositivo
BR0308117A (pt) Dìmeros de avidina eficazes em aumentar a concentração de biotina radioativa em radioimunoterapia pré-direcionada
NL7811814A (nl) Inrichting voor ultrasoon onderzoek van biologische strukturen.
AR014969A1 (es) Formulacion que contienen por lo menos una proteina tardia (proteina l) de uno o mas papilomavirus y/o por lo menos una proteina temprana (proteina e) deuno o mas papilomavirus, procedimiento para la preparacion de la formulacion mencionada asi como su utilizacion para la manufactura de un medicamen
ES2046217T3 (es) Lanosteroles 14,15-sustituidos y su uso como agentes hipocolesterolemicos.
Ige Grillo et al. A fluorescent histochemical method for the detection of tissue disulphide groups
ES2075803B1 (es) Procedimiento de la deteccion de neumolisina
UA34205A (uk) Спосіб визначення захисної функції плаценти
ES2161538T3 (es) Utilizacion de un veneno de serpiente para provocar la coagulacion por activacion del factor x en xa.